Literature DB >> 15114479

Catastrophic heparin-induced thrombocytopenia/thrombosis syndrome related to the use of a Port-A-Cath in a breast cancer patient receiving chemotherapy.

Ming-Shen Dai1, An-Tie Hsieh, Tsu-Yi Chao.   

Abstract

Heparin-induced thrombocytopenia and thrombosis (HIT/T) syndrome is usually triggered by an immune response after repeated administration of heparin. The syndrome is strongly associated with limb deep vein thrombosis and is potentially life-threatening if unrecognized. We describe the case of a patient with compartment syndrome of the left forearm complicated by HIT/T that developed after Port-A-Cath implantation through the left subclavian vein. Prompt recognition of HIT/T, immediate withdrawal of heparin, and timely institution of thrombolytic therapy successfully prevented limb loss.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15114479     DOI: 10.1007/s00520-004-0631-4

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  11 in total

1.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 15-2002. A 53-year-old man with a myocardial infarct and thromboses after coronary-artery bypass grafting.

Authors:  William C Aird; Eugene J Mark
Journal:  N Engl J Med       Date:  2002-05-16       Impact factor: 91.245

Review 2.  How I treat heparin-induced thrombocytopenia and thrombosis.

Authors:  Barbara M Alving
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

Review 3.  Heparin-induced thrombocytopenia: pathogenesis and management.

Authors:  Theodore E Warkentin
Journal:  Br J Haematol       Date:  2003-05       Impact factor: 6.998

4.  Temporal aspects of heparin-induced thrombocytopenia.

Authors:  T E Warkentin; J G Kelton
Journal:  N Engl J Med       Date:  2001-04-26       Impact factor: 91.245

5.  Heparin-induced thrombocytopenia with thrombosis: successful treatment with plasma exchange.

Authors:  P Poullin; P A Pietri; P Lefèvre
Journal:  Br J Haematol       Date:  1998-07       Impact factor: 6.998

6.  The heparin-induced thrombocytopenia and thrombosis syndrome: treatment with intraarterial urokinase and systemic platelet aggregation inhibitors.

Authors:  K D Murphy; G McCrohan; D A DeMarta; N B Shirodkar; O J Kwon; P S Chopra
Journal:  Cardiovasc Intervent Radiol       Date:  1996 Mar-Apr       Impact factor: 2.740

Review 7.  Heparin induced thrombocytopenia thrombosis (HIT/T) syndrome: diagnosis and treatment.

Authors:  T P Baglin
Journal:  J Clin Pathol       Date:  2001-04       Impact factor: 3.411

Review 8.  Heparin-induced thrombocytopenia and thrombosis: reversal with streptokinase. A case report and review of literature.

Authors:  D P Mehta; E L Yoder; J Appel; K L Bergsman
Journal:  Am J Hematol       Date:  1991-04       Impact factor: 10.047

Review 9.  Limitations of conventional treatment options for heparin-induced thrombocytopenia.

Authors:  T E Warkentin
Journal:  Semin Hematol       Date:  1998-10       Impact factor: 3.851

Review 10.  Central venous catheters and upper-extremity deep-vein thrombosis complicating immune heparin-induced thrombocytopenia.

Authors:  Aaron P Hong; Deborah J Cook; Christopher S Sigouin; Theodore E Warkentin
Journal:  Blood       Date:  2002-12-27       Impact factor: 22.113

View more
  1 in total

1.  Emphasis on the Role of PF4 in the Incidence, Pathophysiology and Treatment of Heparin Induced Thrombocytopenia.

Authors:  M Margaret Prechel; Jeanine M Walenga
Journal:  Thromb J       Date:  2013-04-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.